Hepatitis B Variants: Are Canadians Protected?
DOI:
https://doi.org/10.15273/dmj.Vol32No1.4259Abstract
Hepatitis B virus is common in Canada and is associated with major clinical sequelae. Measures such as vaccination and detection programs have been widely implemented as means of mitigating the impact of HBV on individuals and on the public's health. For over a decade, mutant strains of HBV have been reported in countries throughout the world, with the notable exception of Canada. If certain mutant strains of HBV developed in or were spread to Canada, our existing vaccination and detection programs might not effectively protect Canadians.
Downloads
Published
2004-04-12
How to Cite
Kouyoumdjian, F. G. (2004). Hepatitis B Variants: Are Canadians Protected?. DALHOUSIE MEDICAL JOURNAL, 32(1). https://doi.org/10.15273/dmj.Vol32No1.4259
Issue
Section
Review
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
